Anti muellerian hormone serum levels in women with endometriosis: A case–control study

References

• Ozkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann NY Acad Sci 2008;1127:92–100.
   PubMed Web of Science ®Google Scholar
• Kuivasaari P, Hippeläinen M, Anttila M, Heinonen S. Effect of endometriosis on IVF/ICSI outcome: stage III/IV endometriosis worsens cumulative pregnancy and live-born rates. Hum Reprod 2005;20:3130–3135.
   PubMed Web of Science ®Google Scholar
• Cahill DJ, Wardle PG, Maile LA, Harlow CR, Hull MG. Ovarian dysfunction in endometriosis-associated and un-explained infertility. J Assist Reprod Genet 1997;14:554–557.
   PubMedGoogle Scholar
• Navarro J, Garrido N, Remohí J, Pellicer A. How does endometriosis affect infertility? Obstet Gynecol Clin North Am 2003;30:181–192.
   PubMed Web of Science ®Google Scholar
• Brizek CL, Schlaff S, Pellegrini VA, Frank JB, Worrilow KC. Increased incidence of aberrant morphological phenotypes in human embryogenesis – an association with endometriosis. J Assist Reprod Genet 1995;12:106–112.
   PubMed Web of Science ®Google Scholar
• Matalliotakis IM, Cakmak H, Mahutte N, Fragouli Y, Arici A, Sakkas D. Women with advanced-stage endometriosis and previous surgery respond less well to gonadotropin stimulation, but have similar IVF implantation and delivery rates compared with women with tubal factor infertility. Fertil Steril 2007;88:1568–1572.
   PubMed Web of Science ®Google Scholar
• Al-Fadhli R, Kelly SM, Tulandi T, Tanr SL. Effects of different stages of endometriosis on the outcome of in vitro fertilization. J Obstet Gynaecol Can 2006;28:888–891.
   Google Scholar
• Pepinsky RB, Sinclair LK, Chow EP, Mattaliano RJ, Manganaro TF, Donahoe PK, Cate RL. Proteolytic processing of Mullerian inhibiting substance produces a transforming growth factor-β-like fragment. J Biol Chem 1988;263:18961–18964.
   PubMed Web of Science ®Google Scholar
• de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357–362.
   PubMed Web of Science ®Google Scholar
• Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571–576.
   PubMed Web of Science ®Google Scholar
• Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002;77:468–471.
   PubMed Web of Science ®Google Scholar
• Lie Fong S, Baart EB, Martini E, Schipper I, Visser JA, Themmen AP, de Jong FH, Fauser BJ, Laven JS. Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online 2008;16:664–670.
   PubMed Web of Science ®Google Scholar
• Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B or estradiol. Fertil Steril 2004;82:1323–1329.
   PubMed Web of Science ®Google Scholar
• Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti-müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod 2006;21:2022–2026.
   PubMed Web of Science ®Google Scholar
• Fanchin R, Taieb J, Lozano DH, Ducot B, Frydman R, Bouyer J. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 2005;20:923–927.
   PubMed Web of Science ®Google Scholar
• van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, Themmen AP. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065–3071.
   PubMed Web of Science ®Google Scholar
• Maheshwari A, Porter M, Shetty A, Bhattacharya S. Women's awareness and perceptions of delay in childbearing. Fertil Steril 2008;90:1036–1042.
   PubMed Web of Science ®Google Scholar
• Freeman EW, Gracia CR, Sammel MD, Lin H, Lim LC, Strauss JF IIIrd. Association of anti-Mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril 2007;87:101–106.
   PubMed Web of Science ®Google Scholar
• Werbrouck E, Spiessens C, Meuleman C, D'Hooghe T. No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination. Fertil Steril 2006;86:566–571.
   PubMed Web of Science ®Google Scholar
• Azem F, Lessing JB, Geva E, Shahar A, Lerner-Geva L, Yovel I, Amit A. Patients with stages III and IV endometriosis have a poorer outcome of in vitro fertilization-embryo transfer than patients with tubal infertility. Fertil Steril 1999;72:1107–1109.
   PubMed Web of Science ®Google Scholar
• Díaz I, Navarro J, Blasco L, Simón C, Pellicer A, Remohí J. Impact of stage III-IV endometriosis on recipients of sibling oocytes: matched case–control study. Fertil Steril 2000;74:31–34.
   PubMed Web of Science ®Google Scholar